Germline mutations of CDKN2A, CDK4, TERT, and POT1 genes have been identified as high-risk factors for melanoma susceptibility [21,22,23], whereas MC1R (melanocortin 1 receptor) polymorphic variants are reported in 60.5–82.1% of melanoma [24,25]. Here, CDK4 is linked to melanoma.